MAPT and Alzheimer disease: The simultaneous accrual of both Aβ and hyperphosphorylated tau resulting from CatD deletion is particularly noteworthy when considered together with our earlier discovery that CatD proteolytic activity is inhibited specifically and extremely potently by Aβ42 [9, 23], the Aβ species most strongly linked to AD pathogenesis [2].